Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01693432 | Docetaxel and S-1 for Advanced Esophageal Cancer | unknown | Phase 2 | 37 | Hallym University Medical CenterOTHER | 1 | Aug 23, 2017 | clinicaltrials |
| NCT03254511 | Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer | unknown | Phase 2 | 100 | Mashhad University of Medical SciencesOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT03011255 |
| Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer |
| unknown |
| Phase 2 |
| 20 |
| Shixiu WuOTHER |
| 1 |
| Aug 7, 2017 |
| clinicaltrials |
| NCT03200691 | Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 21 | Hangzhou Cancer HospitalOTHER | 1 | Aug 7, 2017 | clinicaltrials |
| NCT00394433 | Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT03224221 | Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment | unknown | Phase 2 | 189 | The First Affiliated Hospital of Anhui Medical UniversityOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT02959385 | A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer | unknown | Phase 2 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT01807546 | Oral Rigosertib for Squamous Cell Carcinoma | completed | Phase 2 | 64 | Traws Pharma, Inc.INDUSTRY | 1 | Jun 26, 2017 | clinicaltrials |
| NCT02913066 | S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 88 | Mianyang Central HospitalOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT00423150 | Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) | terminated | Phase 2 | 86 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2017 | clinicaltrials |
| NCT01231399 | Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | completed | Phase 1 / Phase 2 | 6 | City of Hope Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT02273713 | The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)(ACTION) | completed | Phase 1 / Phase 2 | 154 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00400114 | Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer | completed | Phase 2 | 36 | University Health Network, TorontoOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00160875 | Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer | completed | Phase 2 / Phase 3 | 54 | University Health Network, TorontoOTHER | 1 | May 4, 2017 | clinicaltrials |
| NCT00816634 | Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma(XP versus XT) | unknown | Phase 2 | 94 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT01704690 | Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer | terminated | Phase 2 / Phase 3 | 4 | Peking UniversityOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT00702884 | Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer | completed | Phase 2 | 25 | Tony Bekaii-SaabOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT00730353 | Sutent + Taxol for Advanced Esophageal Cancer | completed | Phase 2 | 28 | Hoosier Cancer Research NetworkOTHER | 1 | Mar 16, 2017 | clinicaltrials |
| NCT02274012 | Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment | withdrawn | Phase 2 | 0 | Columbia UniversityOTHER | 0 | Mar 14, 2017 | clinicaltrials |
| NCT00069953 | Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 43 | Radiation Therapy Oncology GroupNETWORK | 1 | Feb 17, 2017 | clinicaltrials |
| NCT00448760 | Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery | completed | Phase 2 | 29 | University of MiamiOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT02762474 | Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer | unknown | Phase 1 / Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT02429622 | Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma | completed | Phase 1 / Phase 2 | 80 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 18, 2017 | clinicaltrials |
| NCT03013712 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer(CARTEPC) | unknown | Phase 1 / Phase 2 | 60 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT02166320 | Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent.(StentMig) | completed | Phase 2 | 80 | Karolinska University HospitalOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT00054457 | Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 46 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00100945 | Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer | completed | Phase 2 | 70 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00107341 | Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 37 | Alliance for Clinical Trials in OncologyOTHER | 0 | Dec 13, 2016 | clinicaltrials |
| NCT00022139 | Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 56 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00040859 | Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00836277 | Phase II Study of Irinotecan and Panitumumab | completed | Phase 2 | 24 | Weijing Sun, MD, FACPOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02938195 | Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer | unknown | Phase 2 | 50 | Shanghai Chest HospitalOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00005878 | Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus | completed | Phase 2 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 13, 2016 | clinicaltrials |
| NCT01608022 | A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus | completed | Phase 2 | 48 | Yonsei UniversityOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT02544737 | Apatinib for Metastatic Esophageal Cancer. | unknown | Phase 2 | 29 | Hangzhou Cancer HospitalOTHER | 1 | Aug 26, 2016 | clinicaltrials |
| NCT02879227 | Radiochemotherapy in Elderly Patients With Oesophagus Cancer(Chronos) | completed | Phase 2 | 23 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Aug 25, 2016 | clinicaltrials |
| NCT00176800 | Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma | completed | Phase 2 | 69 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02861690 | Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma | completed | Phase 2 | 72 | Sun Yat-sen UniversityOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT00003137 | Irinotecan in Treating Patients With Advanced Cancer of the Stomach | completed | Phase 2 | 70 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00004235 | Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | completed | Phase 2 | 47 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00268437 | Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 27 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT01129206 | Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy | completed | Phase 2 | 6 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT00544362 | Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery | completed | Phase 1 / Phase 2 | 33 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | May 30, 2016 | clinicaltrials |
| NCT01870791 | Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer | terminated | Phase 2 | 21 | University Hospitals, LeicesterOTHER | 1 | May 26, 2016 | clinicaltrials |
| NCT02644863 | Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer | unknown | Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT00354679 | Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer | completed | Phase 2 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 16, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Aug 23, 2017source: clinicaltrials